Industry
Danaher Acquires Integrated DNA Technologies
Danaher Corporation has entered into a definitive agreement to acquire Integrated DNA Technologies (IDT), a privately held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. More...13 Mar 2018

Immunofluorescence Assay Market Worth USD 2 Billion by 2023
The global immunofluorescence assay market estimated to be worth USD 1.51 billion in 2018 and is projected to grow at a CAGR of 5.8% to reach USD 2.01 billion by 2023, driven by the growing prevalence of chronic diseases, increasing R&D spending, and rise in healthcare spending. More...01 Mar 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions. More...27 Feb 2018
Molecular POC Market to Reach USD 510 Million by 2023
The molecular point-of-care market (POC), consisting of systems with molecular capability used in decentralized test environments, was worth an estimated USD 165 million in 2017 and is expected to continue growing in the double-digits to reach USD 510 million in 2023. More...27 Feb 2018

Top Factors Driving Global POC Glucose Monitoring Devices Market
The global market for POC blood glucose monitoring devices is expected to grow at a CAGR of over 8% during the period 2018-2022, driven mainly by public and private initiatives to reduce diabetic cases. These are the latest findings of Technavio Research, a global technology research and advisory company. More...23 Feb 2018

QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries. More...13 Feb 2018
In Other News
Top Drivers of Global Laboratory Centrifuge Market
Cancerous Tissue Analysis Introduced Using On-chip Technology
Siemens Healthineers Strategy 2025 to Focus on AI
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
Seegene Develops World’s First Multiplex MDx Assays with AI System
Global POC Infectious Disease Market to Reach USD 1.9 Billion by 2025
Fewer Pathologists and More Cancer Patients Drive Pathology Market
AI Outperforms Pathologists in Diagnosing Breast Cancer
Siemens Healthineers Acquires Fast Track Diagnostics
Google Releases AI Tool for Precision Medicine
GE Launches Drawbridge Health to Transform Blood Collection
Laboratory-Developed Tests Market Driven by Cancer Treatment
Global Lab Automation Market to Reach USD 5.20 Billion by 2022
AI Chip to Help Capture and Analyze Molecular Data in RT
Blood Test Uses AI to Detect Peripheral Artery Disease
Randox to Showcase Future-Proofing Diagnostic Technology at Trade Fair
GNA Biosolutions Reveals New Ultrafast PCR Platform at Medical Trade Show
Diatron to Exhibit Aquila Hematology Analyzer at MEDICA 2017
BBI Solutions to Showcase Technologies for Next-Generation Diagnostics
Global Good and Motic Announce AI-Powered Microscope at MEDICA 2017
Siemens Healthineers Closes Epocal Acquisition
Clinical Chemistry Market to Reach USD 19.7 Billion in 2021
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.




.jpg)



